Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.
2.
3.

Traditional complementary and alternative medicine and antiretroviral treatment adherence among HIV patients in Kwazulu-Natal, South Africa.

Peltzer K, Friend-du Preez N, Ramlagan S, Fomundam H, Anderson J.

Afr J Tradit Complement Altern Med. 2009 Dec 30;7(2):125-37.

4.

Perceived stigma among patients receiving antiretroviral therapy: a prospective study in KwaZulu-Natal, South Africa.

Peltzer K, Ramlagan S.

AIDS Care. 2011 Jan;23(1):60-8. doi: 10.1080/09540121.2010.498864.

PMID:
21218277
5.

The social and clinical characteristics of patients on antiretroviral therapy who are 'lost to follow-up' in KwaZulu-Natal, South Africa: a prospective study.

Peltzer K, Ramlagan S, Khan MS, Gaede B.

SAHARA J. 2011;8(4):179-86. doi: 10.1080/17290376.2011.9725002.

PMID:
23236959
6.

Antiretrovirals and the use of traditional, complementary and alternative medicine by HIV patients in Kwazulu-Natal, South Africa: a longitudinal study.

Peltzer K, Preez NF, Ramlagan S, Fomundam H, Anderson J, Chanetsa L.

Afr J Tradit Complement Altern Med. 2011;8(4):337-45. Epub 2011 Jun 1.

7.

Time to initiation of antiretroviral therapy among patients with HIV-associated tuberculosis in Cape Town, South Africa.

Lawn SD, Campbell L, Kaplan R, Boulle A, Cornell M, Kerschberger B, Morrow C, Little F, Egger M, Wood R; International Epidemiological Databases to Evaluate AIDS-Southern Africa.

J Acquir Immune Defic Syndr. 2011 Jun 1;57(2):136-40. doi: 10.1097/QAI.0b013e3182199ee9.

8.

Low uptake of antiretroviral therapy after admission with human immunodeficiency virus and tuberculosis in KwaZulu-Natal, South Africa.

Murphy RA, Sunpath H, Taha B, Kappagoda S, Maphasa KT, Kuritzkes DR, Smeaton L.

Int J Tuberc Lung Dis. 2010 Jul;14(7):903-8.

9.

Immune recovery after starting ART in HIV-infected patients presenting and not presenting with tuberculosis in South Africa.

Schomaker M, Egger M, Maskew M, Garone D, Prozesky H, Hoffmann CJ, Boulle A, Fenner L; IeDEA Southern Africa.

J Acquir Immune Defic Syndr. 2013 May 1;63(1):142-5. doi: 10.1097/QAI.0b013e318288b39d.

10.

Social support and medication adherence in HIV disease in KwaZulu-Natal, South Africa.

Ncama BP, McInerney PA, Bhengu BR, Corless IB, Wantland DJ, Nicholas PK, McGibbon CA, Davis SM.

Int J Nurs Stud. 2008 Dec;45(12):1757-63. doi: 10.1016/j.ijnurstu.2008.06.006. Epub 2008 Jul 24.

PMID:
18653188
11.

Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa.

Lawn SD, Myer L, Edwards D, Bekker LG, Wood R.

AIDS. 2009 Aug 24;23(13):1717-25. doi: 10.1097/QAD.0b013e32832d3b6d.

12.

Tuberculosis during the first year of antiretroviral therapy in a South African cohort using an intensive pretreatment screening strategy.

Lawn SD, Kranzer K, Edwards DJ, McNally M, Bekker LG, Wood R.

AIDS. 2010 Jun 1;24(9):1323-8. doi: 10.1097/QAD.0b013e3283390dd1.

13.

Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/microl is associated with improved treatment outcomes in South Africa.

Fox MP, Sanne IM, Conradie F, Zeinecker J, Orrell C, Ive P, Rassool M, Dehlinger M, van der Horst C, McIntyre J, Wood R.

AIDS. 2010 Aug 24;24(13):2041-50. doi: 10.1097/QAD.0b013e32833c703e.

14.

Impact of ART on TB case fatality stratified by CD4 count for HIV-positive TB patients in Cape Town, South Africa (2009-2011).

Kaplan R, Caldwell J, Middelkoop K, Bekker LG, Wood R.

J Acquir Immune Defic Syndr. 2014 Aug 15;66(5):487-94. doi: 10.1097/QAI.0000000000000201.

15.

Symptoms experienced by HIV-infected Individuals on antiretroviral therapy in KwaZulu-Natal, South Africa.

Bhengu BR, Ncama BP, McInerney PA, Wantland DJ, Nicholas PK, Corless IB, McGibbon CA, Davis SM, Nicholas TP, Ros AV.

Appl Nurs Res. 2011 Feb;24(1):1-9. doi: 10.1016/j.apnr.2009.01.001. Epub 2009 Jul 9.

PMID:
20974052
16.

Inequalities in HIV disease management and progression in migrants from Latin America and sub-Saharan Africa living in Spain.

Monge S, Alejos B, Dronda F, Del Romero J, Iribarren JA, Pulido F, Rubio R, Miró JM, Gutierrez F, Del Amo J; CoRIS.

HIV Med. 2013 May;14(5):273-83. doi: 10.1111/hiv.12001. Epub 2012 Nov 21. Erratum in: HIV Med. 2014 Jan;15(1):64.

17.

Time to initiation of antiretroviral therapy in HIV-infected patients diagnosed with an opportunistic disease: a cohort study.

Deconinck L, Yazdanpanah Y, Gilson RJ, Melliez H, Viget N, Joly V, Sabin CA.

HIV Med. 2015 Apr;16(4):219-29. doi: 10.1111/hiv.12201. Epub 2014 Dec 18.

18.

Adherence in the treatment of patients with extensively drug-resistant tuberculosis and HIV in South Africa: a prospective cohort study.

OʼDonnell MR, Wolf A, Werner L, Horsburgh CR, Padayatchi N.

J Acquir Immune Defic Syndr. 2014 Sep 1;67(1):22-9. doi: 10.1097/QAI.0000000000000221.

20.

High HIV testing uptake and linkage to care in a novel program of home-based HIV counseling and testing with facilitated referral in KwaZulu-Natal, South Africa.

van Rooyen H, Barnabas RV, Baeten JM, Phakathi Z, Joseph P, Krows M, Hong T, Murnane PM, Hughes J, Celum C.

J Acquir Immune Defic Syndr. 2013 Sep 1;64(1):e1-8. doi: 10.1097/QAI.0b013e31829b567d.

Supplemental Content

Support Center